Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,890
-430 (-3.80%)
Jul 21, 2025, 3:30 PM KST

Oncocross Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
135,25175,179----
Enterprise Value
118,66762,376----
Last Close Price
11320.006340.00----
PS Ratio
125.9070.12----
PB Ratio
7.383.68----
P/TBV Ratio
7.403.68----
EV/Sales Ratio
110.4658.18----
Debt / Equity Ratio
0.020.030.010.050.20-1.14
Asset Turnover
0.060.050.010.010.01-
Quick Ratio
16.9011.3515.164.477.871.05
Current Ratio
17.1811.4215.254.597.931.06
Return on Equity (ROE)
-43.44%-35.10%-36.33%-114.08%--
Return on Assets (ROA)
-27.25%-21.69%-32.76%-53.18%-27.13%-
Return on Capital (ROIC)
-28.49%-23.15%-36.02%-61.28%-60.40%-
Earnings Yield
-5.37%-8.62%----
FCF Yield
-5.85%-7.56%----
Buyback Yield / Dilution
-16.48%-17.49%-1.44%-63.74%-0.83%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.